MITF and melanoma: Quantitative analysis of β-catenin protein as well as its functional activation, measured by quantification of mRNA levels of the ubiquitously target gene AXIN2 and of the melanocyte specific marker MITF showed a heterogeneous level of WNT pathway activation in melanoma cells (Figure 2A, 2B).